Physician profile
Enna Chen
NPI 1700395621
$726.17
in general payments reported to CMS, 2019-2025
12 companies · $579 in 2025
The $579 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.01 · 2023: $64.51 · 2024: $67.44 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $150.00 | 2025 | |
| Lilly USA, LLC | $124.87 | 2025 | Kisunla |
| Dexcom, INC. | $100.61 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Gilead Sciences, INC. | $100.26 | 2021-2025 | Biktarvy, Yeztugo |
| Dynavax Technologies Corporation | $44.80 | 2023-2025 | Heplisav-B |
| Pfizer INC. | $42.33 | 2023-2024 | |
| Glaxosmithkline, LLC. | $38.39 | 2024-2025 | Shingrix, Arexvy |
| Exact Sciences Corporation | $35.11 | 2025 | Cologuard Collection Kit |
| Seqirus USA INC | $29.96 | 2025 | Fluad, Flucelvax |
| Alkermes, INC. | $21.12 | 2023 | Vivitrol |
| Hologic Sales and Service, LLC | $20.62 | 2025 | Aptima |
| Coopersurgical, INC. | $18.10 | 2025 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Enna Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.